Onetime, potentially curative treatments for hemophilia represent the first 'big wave' in the gene therapy space. Moderated by Larry Blandford of PRECISIONvalue, join us as we explore the challenges, and discuss solutions to getting new and innovative gene therapy therapies into the hands of patients who need them most.
Join Precision and Akara Group for a special, online discussion of best practices for pre-launch commercialization activities.
Historic unemployment rates have dramatically shifted healthcare coverage trends as a result of COVID-19. Watch on-demand with PRECISIONadvisors' Greg Gregory and Eddie Vogel, and learn we can address the impact of these shifts, and help support your teams' ability to answer tough questions moving forward.
Launching a drug requires a robust strategy to understanding payer decision-making. In this webinar with Precision's Brett DiNatale and Diego Etcheto, learn how our rigorous, standardized, 3-step methodology can help you predict future actions for your entire payer spectrum.
In this on-demand webinar, a panel of Precision's top gene and cell therapy leaders tackles the challenge of how to demonstrate the short and long-term value of a therapy when clinical data is lacking.
Adapted from recent presentations at the AMCP and ISPOR conferences, this webinar will provide an overview of value-based contracting and some of the key challenges to successful implementation.
This expert panel tackle head-on some of the hottest topics and trends in health economics and outcomes research today, and what you need to know to be successful in 2020.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
